The identification of novel reverse-transcriptase (RT) drug-resistance mutations is critical in predicting the probability of success to anti-HBV treatment. Furthermore, due to HBV-RT/HBsAg gene-overlap, they can have an impact on HBsAg-detection and quantification.
Cento, V., Van Hemert, F., Neumann Fraune, M., Mirabelli, C., Di Maio, V., Salpini, R., et al. (2013). Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen. JOURNAL OF INFECTION, 67(4), 303-312 [10.1016/j.jinf.2013.05.008].
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen
Salpini, R;BERTOLI, ADA;SARRECCHIA, CESARE;CECCHERINI SILBERSTEIN, FRANCESCA;ANDREONI, MASSIMO;ANGELICO, MARIO;SVICHER, VALENTINA
2013-06-22
Abstract
The identification of novel reverse-transcriptase (RT) drug-resistance mutations is critical in predicting the probability of success to anti-HBV treatment. Furthermore, due to HBV-RT/HBsAg gene-overlap, they can have an impact on HBsAg-detection and quantification.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2013_AntiHBV treatment induces novel reverse trascriptase mutations with reflective effect on HBV S antigen_Cento.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
1.49 MB
Formato
Adobe PDF
|
1.49 MB | Adobe PDF | Visualizza/Apri |
|
L5.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Licenza:
Creative commons
Dimensione
1.43 MB
Formato
Unknown
|
1.43 MB | Unknown | Visualizza/Apri Richiedi una copia |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
